AUPH Aurinia Pharmaceuticals Inc

USD 5.43 -0.13 -2.338129
Icon

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 5.43

-0.13 (-2.34)%

USD 0.80B

1.52M

USD 9.67(+78.02%)

USD 25.00 (+360.41%)

Icon

AUPH

Aurinia Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 5.43
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 0.80B

USD 25.00 (+360.41%)

USD 5.43

Aurinia Pharmaceuticals Inc (AUPH) Stock Forecast

Show ratings and price targets of :
USD 9.67
(+78.02%)

Based on the Aurinia Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for Aurinia Pharmaceuticals Inc is USD 9.67 over the next 12 months. Aurinia Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aurinia Pharmaceuticals Inc is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, Aurinia Pharmaceuticals Inc’s stock price was USD 5.43. Aurinia Pharmaceuticals Inc’s stock price has changed by -4.23% over the past week, -1.81% over the past month and -50.37% over the last year.

No recent analyst target price found for Aurinia Pharmaceuticals Inc
No recent average analyst rating found for Aurinia Pharmaceuticals Inc

Company Overview Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephrit...Read More

118 Avenue , 14315, Edmonton, AB, Canada, T5L 4S6

300

December

USD

USA

Adjusted Closing Price for Aurinia Pharmaceuticals Inc (AUPH)

Loading...

Unadjusted Closing Price for Aurinia Pharmaceuticals Inc (AUPH)

Loading...

Share Trading Volume for Aurinia Pharmaceuticals Inc Shares

Loading...

Compare Performance of Aurinia Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AUPH

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aurinia Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.34 (+0.88%) USD126.85B 31.94 20.00

ETFs Containing AUPH

Symbol Name AUPH's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aurinia Pharmaceuticals Inc (AUPH) Stock

Based on ratings from 3 analysts Aurinia Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on AUPH's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for AUPH is USD 9.67 over the next 12 months. The maximum analyst target price is USD 13 while the minimum anlayst target price is USD 8.

Unfortunately we do not have enough data on AUPH's stock to indicate if its overvalued.

The last closing price of AUPH's stock was USD 5.43.

The most recent market capitalization for AUPH is USD 0.80B.

Based on targets from 3 analysts, the average taret price for AUPH is projected at USD 9.67 over the next 12 months. This means that AUPH's stock price may go up by +78.02% over the next 12 months.

We can't find any ETFs which contains Aurinia Pharmaceuticals Inc's stock.

As per our most recent records Aurinia Pharmaceuticals Inc has 300 Employees.

Aurinia Pharmaceuticals Inc's registered address is 118 Avenue , 14315, Edmonton, AB, Canada, T5L 4S6. You can get more information about it from Aurinia Pharmaceuticals Inc's website at https://www.auriniapharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...